Population, Clinical and Applied Prevention Research on Electronic Nicotine Delivery Systems (ENDS)
Multiple entities within NIH invite R01 and R21 applications for Population, Clinical and Applied Prevention Research on Electronic Nicotine Delivery Systems (ENDS) to support studies on electronic nicotine delivery systems (ENDS) that examine population-based, clinical and applied prevention of disease, including etiology of use, epidemiology of use, potential risks, benefits and impacts on other tobacco use behavior among different populations. Multiple awards may be made under each announcement. Program eligibility is unrestricted domestically. Standard due dates apply for the R01 and R21 grant mechanisms.
Standard R01, R21 dates apply.